Terms: = Gastric cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
118 results:
1. RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition.
Dong W; Li X; Cheng L; Yang J; Zhao Z; Qiang X; Li P; Wu J; Guo L
Arch Biochem Biophys; 2024 Apr; 754():109896. PubMed ID: 38417691
[TBL] [Abstract] [Full Text] [Related]
2. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the erk1/2 and JAK/STAT pathways.
Ito Y; Kanda M; Sasahara M; Tanaka C; Shimizu D; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Gastric Cancer; 2024 May; 27(3):506-518. PubMed ID: 38386237
[TBL] [Abstract] [Full Text] [Related]
3. Homeobox Protein BarH-like 1 Promotes gastric cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
Gu Y; Chen G; Ning X
Dig Dis Sci; 2024 Apr; 69(4):1182-1199. PubMed ID: 38358459
[TBL] [Abstract] [Full Text] [Related]
4. Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.
Beyer GV; Hueser S; Li R; Manika D; Lee M; Chan CHF; Howe JR; Ear PH
Surgery; 2024 Mar; 175(3):605-612. PubMed ID: 37914572
[TBL] [Abstract] [Full Text] [Related]
5. Identification of RECK as a protective prognostic indicator and a tumor suppressor through regulation of the erk/MAPK signaling pathway in gastric cancer.
Qi F; Wang Y; Yu B; Li F
J Transl Med; 2023 Oct; 21(1):766. PubMed ID: 37904179
[TBL] [Abstract] [Full Text] [Related]
6. CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages.
Zhang G; Gao Z; Guo X; Ma R; Wang X; Zhou P; Li C; Tang Z; Zhao R; Gao P
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37707957
[TBL] [Abstract] [Full Text] [Related]
7. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract] [Full Text] [Related]
8. SIGLEC10
Guo Y; Ke S; Xie F; Chen J; Liu X; Wang Z; Xu D; Shen Y; Zhao G; Zhao W; Lu H
Cancer Immunol Immunother; 2023 Oct; 72(10):3229-3242. PubMed ID: 37432407
[TBL] [Abstract] [Full Text] [Related]
9. JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis.
Li S; Wei Y; Sun X; Liu M; Zhu M; Yuan Y; Zhang J; Dong Y; Hu K; Ma S; Zhang X; Xu B; Jiang H; Gan L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1784-1796. PubMed ID: 37337631
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract] [Full Text] [Related]
11. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking.
Yadav RP; Sadhukhan S; Saha ML; Ghosh S; Das M
Sci Rep; 2022 Nov; 12(1):18413. PubMed ID: 36319798
[TBL] [Abstract] [Full Text] [Related]
12. gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis.
Qiu S; Xie L; Lu C; Gu C; Xia Y; Lv J; Xuan Z; Fang L; Yang J; Zhang L; Li Z; Wang W; Xu H; Li B; Xu Z
J Exp Clin Cancer Res; 2022 Oct; 41(1):296. PubMed ID: 36217165
[TBL] [Abstract] [Full Text] [Related]
13. Minichromosome Maintenance 4 Is Associated with cancer Stemness and Poor Survival of Patients with gastric cancer.
Katsuya N; Ishikawa A; Kido A; Fukui T; Kobayashi G; Sekino Y; Uraoka N; Babasaki T; Yasui W; Sentani K; Oue N
Pathobiology; 2023; 90(3):147-154. PubMed ID: 35830849
[TBL] [Abstract] [Full Text] [Related]
14. Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers.
Liu B; Katoh H; Komura D; Yamamoto A; Ochi M; Onoyama T; Abe H; Ushiku T; Seto Y; Suo J; Ishikawa S
J Pathol; 2022 Oct; 258(2):106-120. PubMed ID: 35696251
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in gastric cancer.
Hu X; Chen M; Ruan Q; Shi C; Pan J; Luo L
J Immunol Res; 2022; 2022():2039447. PubMed ID: 35647201
[TBL] [Abstract] [Full Text] [Related]
16. HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3.
Zang WJ; Hu YL; Qian CY; Feng Y; Liu JZ; Yang JL; Huang H; Zhu YZ; Xue WJ
Br J Cancer; 2022 Jul; 127(2):237-248. PubMed ID: 35637410
[TBL] [Abstract] [Full Text] [Related]
17. ZFP36L1 Promotes gastric cancer Progression
Ding K; Zhang F; Qi G; Lin M; Chen M; Chen Y; Zheng J; Zhou F
Recent Pat Anticancer Drug Discov; 2023; 18(1):80-91. PubMed ID: 35611776
[TBL] [Abstract] [Full Text] [Related]
18. Reticulon 2 promotes gastric cancer metastasis via activating endoplasmic reticulum Ca
Song S; Liu B; Zeng X; Wu Y; Chen H; Wu H; Gu J; Gao X; Ruan Y; Wang H
Cell Death Dis; 2022 Apr; 13(4):349. PubMed ID: 35428758
[TBL] [Abstract] [Full Text] [Related]
19. ThPOK inhibits the immune escape of gastric cancer cells by inducing STPG1 to inactivate the erk pathway.
Chen Y; Jiang L; Xia L; Zhang G; Chen L
BMC Immunol; 2022 Apr; 23(1):16. PubMed ID: 35379170
[TBL] [Abstract] [Full Text] [Related]
20. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
[Next]
